Free Access
Volume 84, Number 1-2, January-April 2004
12th Meeting of the " Club des Bactéries Lactiques ".
Page(s) 191 - 206
References of  Lait 84 (2004) 191-206
  1. Barth H., Klein R., Berg P.A., Wiedenmann B., Hopf U., Berg T., Induction of T helper cell type 1 response and elimination of HbeAg during treatment with IL-12 in a patient with respiratory-refractory chronic hepatitis B, Hepato-Gastroenterol. 48 (2001) 553-555.
  2. Bermúdez-Humarán L.G., Langella P., Miyoshi A., Gruss A., Taméz-Reyes R.S., Montes de Oca-Luna R., Le Loir Y., Production of human papillomavirus type 16 E7 protein in Lactococcus lactis, Appl. Environ. Microbiol. 68 (2002) 917-922 [CrossRef] [PubMed].
  3. Bermúdez-Humarán L.G., Langella P., Cortez-Perez N., Gruss A., Tamez-Guerra R.S., Oliveira S.C., Sauceda-Cardenas O., Montes de Oca-Luna R., Le Loir Y., Intranasal administration of recombinant Lactococcus lactis secreting murine interleukine-12 enhances antigen-specific Th1 cytokine production, Infect. Immun. 71 (2003) 1887-1896 [CrossRef] [PubMed].
  4. Bermúdez-Humarán L.G., Cortes-Perez N.G., Le Loir Y., Gruss A., Rodríguez-Padilla C., Saucedo-Cardenas O., Langella P., Montes de Oca-Luna R., Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis, Biotechnol. Progr. 19 (2003) 1101-1104.
  5. Bolhuis A., Tjalsma H., Smith H.E., de Jong A., Meima R., Venema G., Bron S., van Dijl J.M., Evaluation of bottlenecks in the late stages of protein secretion in Bacillus subtilis, Appl. Environ. Microbiol. 65 (1999) 2934-2941 [PubMed].
  6. Boyaka P.N., McGhee J.R., Cytokines as adjuvants for the induction of mucosal immunity, Adv. Drug. Deliv. Rev. 51 (2001) 71-79 [CrossRef] [PubMed].
  7. Chen B., Timiryasova T.M., Gridley D.S., Andres M.L., Dutta-Roy R., Fodor I., Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy, Cytokine 15 (2001) 305-134 [CrossRef] [PubMed].
  8. Cortes-Perez N.G., Bermúdez-Humarán L.G., Langella P., Rodriguez-Padilla C., Gruss A., Le Loir Y., Montes de Oca-Luna R., Mice immunization with live lactococci displaying a surface anchored HPV16-E7 oncoprotein, FEMS Microbiol. Lett. 229 (2003) 37-42 [CrossRef] [PubMed].
  9. de Ruyter P.G., Kuipers O.P., de Vos W.M., Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin, Appl. Environ. Microbiol. 62 (1996) 3662-3667 [PubMed].
  10. Dieye Y., Usai S., Clier F., Gruss A., Piard J.C., Optimizing protein targeting in lactic acid bacteria, J. Bacteriol. 183 (2001) 4157-4166 [CrossRef] [PubMed].
  11. Drouault S., Corthier G., Ehrlich S.D., Renault P., Survival, physiology, and lysis of Lactococcus lactis in the digestive tract, Appl. Environ. Microbiol. 65 (1999) 4881-4886 [PubMed].
  12. Enouf V., Langella P., Commissaire J., Cohen J., Corthier G., Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol. 67 (2001) 1423-1428 [CrossRef] [PubMed].
  13. Gasson M.J., Plasmid complements of Streptococcus lactis NCDO 712 and other lactic acid streptococci after protoplast-induced curing, J. Bacteriol. 154 (1983) 1-9 [PubMed].
  14. Ghim S.J., Sundberg J., Delgado G., Jenson A.B., The pathogenesis of advanced cervical cancer provides the basis for an empirical therapeutic vaccine, Exp. Mol. Pathol. 71 (2001) 181-185 [CrossRef] [PubMed].
  15. Gibson T.J., Studies of the Eppstein-Barr virus genome, Ph.D. thesis, University of Cambridge, Cambridge, England, 1984.
  16. Hultgren O.H., Stenson M., Tarkowski A., Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis, Arthrit. Res. 3 (2001) 41-47.
  17. Jacobson M.A., Hardy D., Connick E., Watson J., DeBruin M., Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL, J. Infect. Dis. 182 (2000) 1070-1076 [CrossRef] [PubMed].
  18. Kuipers O.P., de Ruyter P.G., Kleerebezen M., de Vos W.M., Quorum sensing-controlled gene expression in lactic acid bacteria, J. Biotechnol. 64 (1998) 15-21 [CrossRef].
  19. Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685 [PubMed].
  20. Langella P., Le Loir Y., Ehrlich S.D., Gruss A., Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis, J. Bacteriol. 175 (1993) 5806-5813 [PubMed].
  21. Le Loir Y., Gruss A., Ehrlich S.D., Langella P., A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis, J. Bacteriol. 180 (1998) 1895-1903 [PubMed].
  22. Leonard J.P., Sherman M.L., Fisher G.L., Buchanan L.J., Larsen G., Atkins M.B., Sosman J.A., Dutcher J.P., Vogelzang N.J., Ryan J.L., Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production, Blood 90 (1997) 2541-2548 [PubMed].
  23. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., Su C., Pan Y.C.E., Hakimi J., Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity, J. Immunol. 154 (1995) 116-127 [PubMed].
  24. Lui V.W., Falo L.D., Huang L., Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo, J. Gene Med. 3 (2001) 384-393 [CrossRef] [PubMed].
  25. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., van Cleave V.H., Dunnick W.A., Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms, Eur. J. Immunol. 27 (1997) 1958-1965 [PubMed].
  26. Michel N., Osen W., Gissmann L., Schumacher T.N., Zentgraf H., Muller M., Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination, Virology 294 (2002) 47-59 [CrossRef] [PubMed].
  27. Nastala C., Edington H., McKinney T., Tahara H., Nalesnik M., Brunda M., Gately M.K., Wolf S., Schreiber R., Storkus W., Lotze M., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production, J. Immunol. 153 (1994) 1697-1703 [PubMed].
  28. Nouaille S., Ribeiro L.A., Miyoshi A., Pontes D., Le Loir Y., Oliveira S.C., Langella P., Azevedo V., Heterologous protein production and delivery systems for Lactococcus lactis, Genet. Mol. Res. 2 (2003) 102-111 [PubMed].
  29. Paik S.H., Chakicherla A., Hansen J.N., Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168, J. Biol. Chem. 273 (1998) 23134-23142 [CrossRef] [PubMed].
  30. Park A.Y., Hondowicz B., Kopf M., Scott P., The role of IL-12 in maintaining resistance to Leishmania major, J. Immunol. 168 (2002) 5771-5777 [PubMed].
  31. Payne M.S., Jackson E.N., Use of alkaline phosphatase fusions to study protein secretion in Bacillus subtilis, J. Bacteriol. 173 (1991) 2278-2282 [PubMed].
  32. Piard J.C., Jimenez-Diaz R., Ehrlich S.D., Fischetti V.A., Gruss A., The M6 protein of Streptococcus pyogenes and its potential as a tool to anchor biologically active molecules at the surface of lactic acid bacteria, Adv. Exp. Med. Biol. 418 (1997) 545-550 [PubMed].
  33. Podlaski F.J., Nandouri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., Chizzonite R., Gately M.K., Stern A.S., Molecular characterization of interleukin-12, Arch. Biochem. Biophys. 294 (1992) 230-237 [PubMed].
  34. Poquet I., Ehrlich S.D., Gruss A., An export-specific reporter designed for Gram-positive bacteria: application to Lactococcus lactis, J. Bacteriol. 7 (1998) 1904-1912.
  35. Rakhmilevich A.L., Turner J., Ford M.J., McCabe D., Sun W.H., Sondel P.M., Grota K., Yang N.Y., Gene gun-mediated skin transfection with interleukin-12 gene results in regression of established and metastatic murine tumors, Proc. Natl. Acad. Sci. USA 93 (1996) 6291-6296 [CrossRef] [PubMed].
  36. Ribeiro L.A., Azevedo V., Le Loir Y., Oliveira S.C., Dieye Y., Piard J.C., Gruss A., Langella P., Efficient targeting of the Brucella abortus immunodominant antigen L7/L12 by Lactococcus lactis: a first step towards new live vaccines against brucellosis, Appl. Environ. Microbiol. 68 (2002) 910-916 [CrossRef] [PubMed].
  37. Sambrook J., Fritsch E.F., Maniatis T., Molecular cloning: a laboratory manual, 2nd edn., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 1989.
  38. Sin J.I., Kim J.J., Arnold R.L., Shroff K.E., McCallus D., Pachuk C., McElhiney S.P., Wolf M.W., Pompa-de Bruin S.J., Higgins T.J., Ciccarelli R.B., Weiner D.B., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge, J. Immunol. 162 (1999) 2912-2921 [PubMed].
  39. Sinkovics J.G., Horvath J.C., Vaccination against human cancers, Int. J. Oncol. 16 (2000) 81-96 [PubMed].
  40. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E., Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science 289 (2000) 1352-1355 [CrossRef].
  41. Trinchieri G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity, Annu. Rev. Immunol. 13 (1995) 251-276 [PubMed].
  42. van Asseldonk M., Rutten G., Oteman M., Siezen R.J., de Vos W.M., Simons G., Cloning, expression in Escherichia coli and characterization of usp45, a gene encoding a highly secreted protein from Lactococcus lactis MG1363, Gene 95 (1990) 155-160 [CrossRef] [PubMed].
  43. Voest E.E., Kenyon B.M., O'Reilly M.S., Truitt G., D'Amato R.J., Folkman J., Inhibition of angiogenesis in vivo by interleukin-12, J. Natl. Cancer Inst. 19 (1995) 581-586.
  44. zur Hausen H., Human papillomaviruses in the pathogenesis of anogenital cancer, Virology 184 (1991) 9-13 [PubMed].